Simvastatin treatment improves endothelial function and increases fibrinolysis in patients with hypercholestrolemia.

OBJECTIVES: Statins reduce cardiovascular events by cholesterol-lowering as well as nonlipid-related actions. Thrombin activatable fibrinolysis inhibitor (TAFI) is a recently identified independent risk factor of thrombosis. Endothelial dysfunction is also a strong predictor of cardiovascular events...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Guven, Gulay S., Atalar, Enver, Yavuz, Bunyamin, Beyazit, Yavuz, Kekilli, Murat, Kilicarslan, Alparslan, Sahiner, Levent, Oz, Gul, Ozer, Necla, Aksoyek, Serdar, Haznedaroglu, Ibrahim C., Sozen, Tumay
Формат: Artigo
Язык:Inglês
Опубликовано: National Medical Association 2006
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2569240/
https://ncbi.nlm.nih.gov/pubmed/16623076
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы